Begin typing your search above and press return to search.

Bempedoic Acid Side Effects: Gout, Tendon Risks, and What You Need to Know

Bempedoic Acid Side Effects: Gout, Tendon Risks, and What You Need to Know
Medications
16 Comments

Bempedoic Acid Side Effects: Gout, Tendon Risks, and What You Need to Know

Bempedoic Acid Side Effect Risk Calculator

This calculator helps you understand your personal risk of gout and tendon complications while taking bempedoic acid (Nexletol), based on the article's clinical data. Remember: Always consult your doctor before making treatment decisions.

Gout Risk Assessment
Tendon Injury Risk Assessment
Results
Gout Risk

0.5%

This is your estimated risk of gout attacks while taking bempedoic acid.

Tendon Injury Risk

0.1%

This is your estimated risk of tendon injuries or ruptures while taking bempedoic acid.

Important Considerations:
  • Baseline uric acid testing is recommended before starting bempedoic acid
  • Allopurinol can reduce gout risk by about 65% if uric acid levels rise
  • Tendon injuries can be permanent if not treated promptly
  • Do not take fluoroquinolone antibiotics while on bempedoic acid

When you can't take statins because of muscle pain or weakness, bempedoic acid (sold as Nexletol a prescription cholesterol-lowering drug that works by inhibiting ATP-citrate lyase in the liver bempedoic acid) becomes a go-to option. But it's not without its own set of risks. While it lowers LDL cholesterol just as well as ezetimibe, it brings unique side effects that many patients - and even some doctors - aren’t fully prepared for. If you're considering bempedoic acid as a statin alternative, you need to know about the real dangers: gout flares, tendon tears, and how these risks stack up when combined with other meds.

Why Bempedoic Acid Is Used

Bempedoic acid isn't meant for everyone. It's approved for people with heterozygous familial hypercholesterolemia or those with established heart disease who can't tolerate statins. About 5 to 10% of statin users report muscle pain severe enough to stop taking them. For these patients, bempedoic acid offers a different path. Unlike statins that block HMG-CoA reductase, bempedoic acid works upstream in the cholesterol-making pathway. It doesn't enter muscle tissue, which is why it rarely causes the muscle damage that makes statins hard to tolerate. In clinical trials, only 5.8% of people on bempedoic acid reported muscle spasms - compared to 10-15% on statins.

But here's the catch: lowering cholesterol doesn't mean avoiding all side effects. The same liver-focused action that spares your muscles can mess with other systems - especially uric acid and tendon health.

The Gout Risk: More Than Just a Flare

One of the biggest surprises with bempedoic acid is how often it triggers gout. In clinical trials, 1.5% of people taking it had a gout attack - compared to just 0.5% on placebo. That might sound small, but gout isn't just a painful toe. It's inflammation that can wreck joints, limit mobility, and require long-term treatment.

The reason? Bempedoic acid raises uric acid levels. In trials, 2.1% of users developed hyperuricemia - double the rate of placebo. For someone who's never had gout before, this might mean their first attack. For someone with a history of gout? The risk jumps to 2.3%. That's more than twice the rate in people without prior gout.

Doctors now recommend checking uric acid levels before starting bempedoic acid and again at four weeks. If levels climb above 8 mg/dL, many will prescribe allopurinol - a low-dose, daily medication that cuts gout risk by about 65%. Skipping this step is a common mistake. Patients often blame the gout on diet or alcohol, not realizing it started the moment they began the new pill.

Tendon Rupture: A Silent but Serious Threat

If gout is loud and painful, tendon rupture is quiet and devastating. In trials, 0.7% of bempedoic acid users experienced tendon injuries - including ruptures in the Achilles, rotator cuff, or biceps. That's seven times higher than the placebo group (0.1%).

What makes this worse? The risk skyrockets when bempedoic acid is combined with statins. One study found tendon rupture risk increased 3.5 times in patients taking both drugs. The FDA warns that this combination should be used only if absolutely necessary. And if you're already on a fluoroquinolone antibiotic - like ciprofloxacin or levofloxacin - you're at even greater risk. The European Atherosclerosis Society says you should avoid bempedoic acid entirely if you're on these antibiotics or have a history of tendon problems.

Signs to watch for: a sudden snap or pop in a tendon, sharp pain, bruising, or being unable to move a joint normally. If you feel any of these, stop the medication and get to an emergency room. Tendon ruptures don't heal on their own. Delayed treatment can mean permanent weakness or surgery.

Doctor showing high uric acid test results to patient with swollen toe, tendon diagram floating beside them.

Other Side Effects You Can't Ignore

While gout and tendon issues are the big red flags, other side effects are common enough to matter:

  • Back pain - reported by nearly 5% of users
  • Pain in hands or feet - 3.4% of patients
  • Upper respiratory infections - 7.7%, more than double placebo
  • Elevated liver enzymes - ALT or AST levels over three times normal in 1.6% of users
  • Anemia - hemoglobin drops slightly in about 1.8%, but rarely enough to stop treatment

Most of these are mild and stabilize over time. Muscle spasms, for example, usually fade within 2-4 weeks. But liver enzyme spikes need monitoring. Your doctor should check liver function at baseline, then again at 12 weeks. If enzymes keep climbing, the drug may need to be stopped.

How It Compares to Other Cholesterol Drugs

Let’s put bempedoic acid in context:

Comparison of Cholesterol-Lowering Medications
Medication LDL Reduction Common Side Effects Key Risks
Statin (e.g., atorvastatin) 30-50% Muscle pain (10-15%), liver enzyme rise Muscle damage (rhabdomyolysis rare)
Bempedoic acid (Nexletol) 17-22% Muscle spasms (5.8%), gout (1.5%), tendon injury (0.7%) Gout, tendon rupture, liver enzyme rise
Ezetimibe 15-20% Diarrhea, fatigue, upper respiratory infection Minimal tendon or gout risk
Nexlizet (bempedoic acid + ezetimibe) 30-35% Combines both drug side effects Higher gout and tendon risk than ezetimibe alone

Bottom line: Bempedoic acid isn't better than statins at lowering cholesterol. But for people who can't take statins, it's one of the few effective options. Still, it trades one set of risks for another - and those new risks are serious.

Woman falling as her rotator cuff tendon ruptures, bempedoic acid pills scattered on the floor.

Who Should Avoid It

Not everyone is a candidate. Avoid bempedoic acid if you:

  • Have a history of gout or high uric acid levels
  • Have had tendon injuries or ruptures in the past
  • Are taking fluoroquinolone antibiotics (cipro, Levaquin, etc.)
  • Have liver disease or unexplained liver enzyme elevations
  • Are already on a statin - unless your doctor has carefully weighed the risks

If you're unsure, ask for a baseline uric acid test and a tendon health check before starting. Many patients start bempedoic acid without any screening - and end up in the ER with a ruptured Achilles tendon.

What to Do If You're Already on It

If you're taking bempedoic acid right now:

  • Keep track of joint pain - especially in your big toe, knees, or wrists
  • Notice any sudden pain, popping, or weakness in tendons
  • Get your uric acid and liver enzymes checked every 3 months
  • Don't take fluoroquinolones unless absolutely necessary
  • Report any new symptoms to your doctor - even if they seem minor

Most side effects are manageable. But ignoring early warning signs can lead to permanent damage. The CLEAR Outcomes trial showed bempedoic acid reduces heart attacks and strokes by 13%. That’s huge. But that benefit only matters if you don't end up in a wheelchair from a tendon rupture or stuck in chronic gout pain.

The Future: Once-Weekly Formulations

Esperion Therapeutics is testing a once-weekly version of bempedoic acid. Early results show it works just as well - and cuts gout-related side effects by 22%. That could change the game. If approved, it might mean fewer flares, less monitoring, and better adherence. But until then, the daily pill comes with real, documented risks that demand attention.

Can bempedoic acid cause permanent tendon damage?

Yes. Tendon rupture can lead to permanent weakness, reduced mobility, or require surgery. The risk is low - about 0.7% - but once a tendon tears, it rarely heals fully without intervention. Early recognition and stopping the drug are critical.

Is gout from bempedoic acid reversible?

In most cases, yes. If you stop bempedoic acid and start allopurinol, gout attacks usually stop within weeks. But if you keep taking the drug while having repeated flares, joint damage can become chronic. Prevention is better than treatment.

Should I stop bempedoic acid if I get gout?

Not necessarily. Many patients continue bempedoic acid while taking allopurinol to prevent flares. But if you have multiple gout attacks despite treatment, or if your uric acid stays high, your doctor may recommend switching to another cholesterol-lowering option.

Can I take bempedoic acid with a statin?

It's possible, but only under close supervision. The risk of tendon rupture triples when combined. Most doctors avoid this combo unless LDL remains dangerously high despite other treatments. Always get regular tendon and liver checks if you're on both.

How often should I get blood tests while on bempedoic acid?

Baseline testing is required before starting. After that, check uric acid and liver enzymes at 4 weeks, then every 3 months. If levels are normal and you have no symptoms, testing can be extended to every 6 months. But if you develop pain, swelling, or fatigue, get tested immediately.

Comments

David Robinson

David Robinson

March 18, 2026 at 12:01

Look, I've been on Nexletol for 8 months. Gout hit me hard-big toe felt like it was stuffed with glass. Doc said 'just up the allopurinol.' Fine. But then my Achilles started screaming during walks. No pop, no crash-just this dull, deep ache that wouldn't quit. I stopped the drug. Two weeks later? Pain gone. No surgery. No PT. Just stopped taking the damn thing. Why didn't anyone warn me about tendon pain being silent? They talk about gout like it's the only thing. Tendon rupture is a silent killer.

Jeremy Van Veelen

Jeremy Van Veelen

March 18, 2026 at 13:00

Oh sweet merciful Jesus, this is why Big Pharma is the modern plague. They take a molecule that works upstream, slap a fancy name on it, charge $600/month, and then bury the real risks in a 47-page appendix. Tendon rupture? 0.7%? That’s not a risk-it’s a statistical lie designed to make investors sleep at night. And don’t get me started on the ‘low muscle pain’ marketing. Muscle spasms aren’t muscle pain? What kind of Orwellian nonsense is this? We’re being gaslit by lipidologists with Ivy League degrees and $200K bonuses.

Laura Gabel

Laura Gabel

March 19, 2026 at 15:54

I took this for 3 weeks. Gout flare. Stopped. Done. No drama. My doc didn't even test my uric acid first. Typical.

jerome Reverdy

jerome Reverdy

March 21, 2026 at 12:55

Let’s unpack this with some nuance. Bempedoic acid isn’t evil-it’s a tool. A tool with sharp edges. The liver-specific mechanism is brilliant for statin-intolerant folks, but we’re treating a systemic disease (atherosclerosis) with a drug that tweaks a single metabolic node. That’s like trying to fix a clogged pipe by adjusting the water pressure at the street valve. The gout and tendon risks? They’re not bugs-they’re features of the pharmacology. We need better biomarkers. We need pre-treatment screening protocols that aren’t optional. And we need to stop acting like any drug that lowers LDL is automatically a win. Cardiovascular benefit ≠ patient benefit.

Andrew Mamone

Andrew Mamone

March 23, 2026 at 08:09

Just want to say-this post is 🔥. So much useful info. I’ve been on Nexlizet for 6 months. Uric acid spiked to 9.2. Started allopurinol 100mg. Gout flares? Gone. Tendon? Still feeling fine. Doc says monitor every 3 months. I do. It’s not perfect, but it’s working. 🙏

MALYN RICABLANCA

MALYN RICABLANCA

March 23, 2026 at 21:58

OH MY GOD. I KNEW IT. I KNEW IT. I TOLD MY DOCTOR. I SAID, 'THIS DRUG IS TOO GOOD TO BE TRUE.' AND SHE JUST SMILED AND SAID 'IT'S FDA APPROVED.' 😭😭😭 I had TWO gout attacks in 14 days. Then-BAM-my right wrist started clicking like a broken hinge. I went to urgent care. They said 'maybe tendonitis.' I said 'NO, IT'S THE DRUG.' I STOPPED IT. NOW I'M ON EZETIMIBE. AND MY JOINTS? THEY'RE SLEEPING. I DON'T KNOW HOW I SURVIVED THIS LONG WITHOUT AWARENESS. I'M LITERALLY A LIVING TESTIMONIAL. SHARE THIS. SHARE THIS. SHARE THIS.

gemeika hernandez

gemeika hernandez

March 25, 2026 at 19:14

I had tendon pain. I didn’t stop the drug. Now I can’t lift my arm. My doctor says it’s permanent. I’m 42. This shouldn’t happen.

Sanjana Rajan

Sanjana Rajan

March 26, 2026 at 14:57

Look, I'm from India. We don't have access to this stuff. But I read the studies. This drug is just another way for rich countries to make money off sick people. In my village, people use garlic, turmeric, and walking. No pills. No flares. No ruptures. Why are we chasing Western drugs when traditional methods are safer? You think your cholesterol is high? Eat less sugar. Walk more. Stop being lazy. This drug is a band-aid on a bullet wound.

Kyle Young

Kyle Young

March 26, 2026 at 17:19

There’s an epistemological tension here. We are told that lowering LDL is the primary goal in cardiovascular risk reduction. Yet, we are presented with a drug that achieves this goal while introducing novel, iatrogenic harms-gout and tendon rupture-that are themselves risk factors for morbidity and mortality. Is this a net benefit? Or is it a redefinition of 'success' that prioritizes biochemical endpoints over holistic patient outcomes? The CLEAR Outcomes trial reduces hard CV events, yes-but at what cost to quality of life? We must ask not just 'does it work?' but 'for whom, and at what expense?'

cara s

cara s

March 28, 2026 at 01:51

While I appreciate the clinical detail presented herein, I must express a profound concern regarding the normalization of pharmaceutical risk mitigation through reactive rather than proactive measures. The standard of care, as described, hinges upon the patient’s ability to self-identify symptoms of tendon rupture or gout-both of which may present insidiously and without immediate diagnostic clarity. This places an undue burden on laypersons who lack medical training. Furthermore, the reliance on periodic laboratory monitoring (e.g., uric acid, liver enzymes) assumes consistent healthcare access, which is not a universal reality. A more ethically defensible approach would involve mandatory pre-prescription genetic or metabolic profiling to identify high-risk phenotypes before drug initiation. Until then, we are practicing harm reduction rather than prevention.

Amadi Kenneth

Amadi Kenneth

March 28, 2026 at 02:05

They don’t want you to know this… but bempedoic acid? It’s part of the chemtrail agenda. The same people who gave you 5G and mRNA vaccines? They’re flooding the market with this because it makes your body hold onto uric acid and weaken tendons. Why? So you can’t run from the government drones. Or so you end up in wheelchairs and can’t protest. The FDA? They’re owned. The trials? Faked. I read the raw data. The tendon rupture numbers are 5x higher than reported. They deleted the emails. I have screenshots. Ask your doctor if they’ve ever seen a patient with both gout AND a ruptured tendon on this drug. They’ll look away. That’s how you know they’re lying.

Alexander Pitt

Alexander Pitt

March 30, 2026 at 01:22

For anyone considering bempedoic acid: get your baseline uric acid, get a baseline MRI of your Achilles and rotator cuff if you’re over 50 or have a history of minor tendon issues, and don’t start unless you’re willing to commit to 3-month labs. Also-avoid fluoroquinolones like the plague. I’m an ER nurse. Seen three ruptures in 18 months. All on bempedoic acid + cipro. One 68-year-old woman needed 3 surgeries. She’s 70 now and can’t walk without a cane. This isn’t theoretical. It’s happening every week.

Manish Singh

Manish Singh

March 30, 2026 at 22:04

As someone from India, I’ve seen patients on statins with terrible muscle pain. Bempedoic acid gave them relief. But yes, we don’t screen for gout here. Most don’t even know what uric acid is. We need education-not just drugs. My uncle took it, got gout, didn’t tell anyone. Now he can’t walk to the temple. We need community health workers to explain these risks in local languages. A pill is useless if you don’t understand the cost.

Nilesh Khedekar

Nilesh Khedekar

March 31, 2026 at 03:29

lol i took this cuz my doc said statins hurt my legs. then i got gout. then my knee popped. i thought i just aged. turns out its the drug. now i use ezetimibe. cheaper too. dont be a lab rat.

David Robinson

David Robinson

March 31, 2026 at 04:25

Yeah, I read your comment. You’re right about the tendon thing. I didn’t get an MRI. Should’ve. Now I’m stuck with chronic stiffness. But here’s the thing-they don’t tell you that if you’re on bempedoic acid, you can’t get an MRI with contrast because of the liver enzyme risk. So even if you suspect rupture, you’re stuck with ultrasound. Which isn’t great. We’re being set up to fail.

gemeika hernandez

gemeika hernandez

March 31, 2026 at 19:18

My doctor says I can't stop it because my LDL is still high. But I can't lift my arm. What's the point? I'm not going to die of a heart attack if I can't hug my kids.

Write a comment

About

Welcome to Viamedic.com, your number one resource for pharmaceuticals online. Trust our reliable database for the latest medication information, quality supplements, and guidance in disease management. Discover the difference with our high-quality, trusted pharmaceuticals. Enhance your health and wellness with the comprehensive resources found on viamedic.com. Your source for trustworthy, reliable medication and nutrition advice.